The Cigna Group (NYSE:CI – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday.
Several other equities analysts have also recently commented on the company. Morgan Stanley reduced their target price on The Cigna Group from $403.00 to $379.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. Oppenheimer cut their price objective on The Cigna Group from $400.00 to $375.00 and set an “outperform” rating for the company in a report on Friday, January 31st. Piper Sandler reaffirmed an “overweight” rating and issued a $348.00 target price (down from $394.00) on shares of The Cigna Group in a research note on Monday, February 3rd. Wells Fargo & Company dropped their target price on shares of The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Finally, Stephens decreased their price target on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, The Cigna Group has a consensus rating of “Buy” and an average price target of $373.69.
The Cigna Group Trading Up 0.9 %
The Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. During the same quarter in the previous year, the firm earned $6.79 earnings per share. On average, equities analysts forecast that The Cigna Group will post 29.77 EPS for the current fiscal year.
Institutional Investors Weigh In On The Cigna Group
Several institutional investors have recently bought and sold shares of CI. TCTC Holdings LLC purchased a new stake in shares of The Cigna Group during the fourth quarter valued at approximately $25,000. Prospera Private Wealth LLC bought a new stake in The Cigna Group during the 3rd quarter valued at $37,000. Collier Financial bought a new stake in The Cigna Group during the 4th quarter valued at $32,000. ORG Wealth Partners LLC purchased a new stake in The Cigna Group during the 4th quarter valued at $34,000. Finally, Harbor Capital Advisors Inc. bought a new stake in The Cigna Group in the 3rd quarter worth $45,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.
The Cigna Group Company Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Read More
- Five stocks we like better than The Cigna Group
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Investing in Commodities: What Are They? How to Invest in Them
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.